These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24950979)

  • 41. Artificial intelligence: A transformative tool in precision oncology.
    McGale J; Liao MJ; Lopci E; Marabelle A; Dercle L
    Oncotarget; 2024 Aug; 15():588-589. PubMed ID: 39186000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 43. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetics and Precision Oncology.
    Werner RJ; Kelly AD; Issa JJ
    Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.
    Letai A; Bhola P; Welm AL
    Cancer Cell; 2022 Jan; 40(1):26-35. PubMed ID: 34951956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
    Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN
    Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
    Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
    J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
    [No Abstract]   [Full Text] [Related]  

  • 48. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
    Beer PA; Cooke SL; Chang DK; Biankin AV
    Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
    [No Abstract]   [Full Text] [Related]  

  • 49. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.
    Tian Q; Price ND; Hood L
    J Intern Med; 2012 Feb; 271(2):111-21. PubMed ID: 22142401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delivering precision oncology to patients with cancer.
    Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
    Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical Oncology in the Age of Genomic Medicine.
    Weber TK
    Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545
    [No Abstract]   [Full Text] [Related]  

  • 52. Personalised Medicine and Medical Imaging: Opportunities and Challenges for Contemporary Health Care.
    Atutornu J; Hayre CM
    J Med Imaging Radiat Sci; 2018 Dec; 49(4):352-359. PubMed ID: 30514550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
    Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Local advances and challenges in the molecular diagnosis of solid tumors: a health perspective towards precision oncology in Chile].
    Marcelain K; Selman-Bravo C; García-Bloj B; Bustamante E; Fernández J; Gaete F; Moyano L; Bustos JC; Plaza-Parroquia F; Godoy JA; Garrido M; Labbé TP; Ríos JA
    Rev Med Chil; 2023 Oct; 151(10):1344-1360. PubMed ID: 39093138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Network science in clinical trials: A patient-centered approach.
    Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
    Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
    Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
    Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Artificial intelligence, molecular subtyping, biomarkers, and precision oncology.
    Shen JP
    Emerg Top Life Sci; 2021 Dec; 5(6):747-756. PubMed ID: 34881776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.